Genelux (GNLX) financial statements
Genelux reported revenue of $8,000 in fiscal 2025, down 91.0% a year over 3 years.
Net income was -$32M and the operating margin -415175.0%, against -27.2% in 2022.
Free cash flow was -$26M.
The diluted share count rose 308% over the period (dilution).
Revenue and free cash flow
Fiscal years, $ billions.
Income statement
Fiscal years, from Genelux's 10-K filings with the SEC.
| Fiscal year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $11M | $170,000 | $8,000 | $8,000 |
| Research and development | $9M | $13M | $19M | $20M |
| Selling, general and admin | $5M | $12M | $13M | $13M |
| Operating income | -$3M | -$24M | -$32M | -$33M |
| Interest expense | — | $173,000 | — | — |
| Income tax | $1M | — | — | — |
| Net income | -$5M | -$28M | -$30M | -$32M |
| EPS (diluted) | -$0.57 | -$1.16 | -$0.95 | -$0.86 |
| Diluted shares | 9M | 24M | 31M | 37M |
| Operating margin | -27.2% | -14214.7% | -396200.0% | -415175.0% |
| Net margin | -47.0% | -16645.3% | -373362.5% | -401812.5% |
Balance sheet
Fiscal years, from Genelux's 10-K filings with the SEC.
| Fiscal year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Cash and short-term investments | $397,000 | $23M | $31M | $5M |
| Total current assets | $2M | $24M | $32M | $15M |
| Property, plant and equipment | $644,000 | $1M | $1M | $2M |
| Total assets | $6M | $28M | $35M | $19M |
| Total current liabilities | $32M | $7M | $7M | $6M |
| Total liabilities | $41M | $8M | $8M | $7M |
| Shareholders' equity | -$36M | $19M | $26M | $12M |
| Net debt | -$397,000 | -$9M | -$9M | -$5M |
Cash flow
Fiscal years, from Genelux's 10-K filings with the SEC.
| Fiscal year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating cash flow | -$4M | -$20M | -$21M | -$25M |
| Capital spending | $49,000 | $1M | $381,000 | $1M |
| Free cash flow | -$4M | -$21M | -$22M | -$26M |
| Stock-based compensation | $2M | $3M | $6M | $6M |
| Net borrowing | — | -$2M | — | — |
| Free cash flow margin | -32.7% | -12529.4% | -270112.5% | -329575.0% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for GNLX.
Open GNLX in InvestinglyQuestions
What was Genelux's revenue in 2025?
$8,000 in fiscal 2025, from its 10-K filing.
How much free cash flow does Genelux generate?
-$26M in fiscal 2025 (operating cash flow minus capital spending).
From Genelux's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.